Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Chiron/Ortho v. International Murex

This article was originally published in The Gray Sheet

Executive Summary

Chiron/Ortho v. International Murex: U.K. Court of Appeals rules that the Hepatitis C (HCV) immunoassay tests manufactured by Murex Diagnostics Ltd. and United Biomedical Inc. (UBI) infringe primary claims relating to Chiron's U.K. HCV patent, No. GB 2,212,511. The court made its decision after Chiron re-amended its HCV patent by deleting claims that cover non-HCV products; the ruling confirms that Murex and UBI still infringe the re-amended patent. Murex says it will continue to challenge Chiron and Ortho's "anti-competitive domination" of the HCV market by requesting a review of the situation from the European Commission. A trial is scheduled to begin in July of 1996 to determine the amount of damages to be assessed against Murex and UBI...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005024

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel